Introduction
Oxygen therapy is commonly administered in critical care and emergency medicine. Its benefits are well known but potential side-effects may be underestimated. Compliance to recommendations remains dependent on staff workload. We developed FreeO 2 , an innovative device that automatically titrates oxygen flow delivered through nasal cannulas or masks to maintain the patients in the SpO 2 target set by the clinician 1 .
Objectives
To compare FreeO 2 with oxygen manual adjustment, in patient admitted to the emergency department (ED) for acute respiratory failure (ARF).
Methods
We conducted a multicentre randomized controlled study. Inclusion criteria were: admission to ED for ARF requiring O 2 ≥3L/min. Main exclusion criteria were: O 2 ≥15 L/min, immediate need for ventilatory support. After inclusion, patients were randomized to either FreeO 2 or conventional O 2 manual adjustment during 3 hours. The randomization was web-based and stratified for the type of respiratory failure (hypoxemia/hypercapnia) and for the centre. Primary outcome was the % of time with SpO 2 within the predefined target (92-96% for hypoxemic patients; 88-92% for hypercapnic patients). Secondary endpoints were: frequency of severe hypoxemia (SpO 2 < 85%) and hyperoxia (SpO 2 > 98%), partial or complete oxygen weaning at the ED, total O 2 duration, ventilator support use, ICU admissions, ICU and hospital LOS.
Results

patients were randomized (93 FreeO 2 and 94 Manual).
Baseline physiological characteristics were similar in the 2 groups: age = 76 ± 12 yrs., 35% of COPD patients; mean O 2 flow at inclusion was 5.8 ± 3.1 L/min. No serious adverse events related to the protocol or device was recorded. The percentage of time within the SpO 2 target was 81 ± 21% in the FreeO 2 arm and 51 ± 30% in the Manual arm (P < 0.001). Percentage of time with severe hypoxemia and with hyperoxia were significantly lower with FreeO 2 (P < 0.001). The percentage of patients with O 2 flow reduction of more than 50% during the 3 hours of the study was 39% with FreeO 2 vs 19% in the Manual arm (P = 0.011). Percentage of O 2 weaning at the end of the study (3h) was 4.3% in the FreeO 2 arm vs. 14.1 % in the Manual arm; p < 0.001. Significantly less patients in the hypercapnic subgroup were transferred in the ICU, overall O 2 administration and hospital LOS were significantly reduced in the non-adjusted analysis (9.2 ± 6.9 vs 11.1 ± 7.0, P = 0.01).
Conclusions
The automation of oxygen therapy with FreeO 2 at the ED improves the oxygenation parameters with more time in the specified SpO 2 target, less desaturation and less hyperoxia. FreeO 2 may reduce staff workload and improve the compliance to recommendations for oxygen administration with potential related clinical benefits
